NO985023L - Sulfonamidsubstituerte benzopyranderivater, fremgangsmÕter for deres fremstilling, deres anvendelse som medikament samt farmas°ytiske preparater inneholdende forbindelsene - Google Patents
Sulfonamidsubstituerte benzopyranderivater, fremgangsmÕter for deres fremstilling, deres anvendelse som medikament samt farmas°ytiske preparater inneholdende forbindelseneInfo
- Publication number
- NO985023L NO985023L NO985023A NO985023A NO985023L NO 985023 L NO985023 L NO 985023L NO 985023 A NO985023 A NO 985023A NO 985023 A NO985023 A NO 985023A NO 985023 L NO985023 L NO 985023L
- Authority
- NO
- Norway
- Prior art keywords
- sulfonamide
- medicament
- compounds
- processes
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/70—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
- C07D311/72—3,4-Dihydro derivatives having in position 2 at least one methyl radical and in position 6 one oxygen atom, e.g. tocopherols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19748469A DE19748469A1 (de) | 1997-11-03 | 1997-11-03 | Sulfonamid-substituierte Benzopyranderivate, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen |
Publications (2)
Publication Number | Publication Date |
---|---|
NO985023D0 NO985023D0 (no) | 1998-10-28 |
NO985023L true NO985023L (no) | 1999-05-04 |
Family
ID=7847428
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO985023A NO985023L (no) | 1997-11-03 | 1998-10-28 | Sulfonamidsubstituerte benzopyranderivater, fremgangsmÕter for deres fremstilling, deres anvendelse som medikament samt farmas°ytiske preparater inneholdende forbindelsene |
Country Status (29)
Country | Link |
---|---|
US (1) | US6008245A (ja) |
EP (1) | EP0913396B1 (ja) |
JP (1) | JP4430749B2 (ja) |
KR (1) | KR19990044961A (ja) |
CN (1) | CN1218050A (ja) |
AR (1) | AR015997A1 (ja) |
AT (1) | ATE250051T1 (ja) |
AU (1) | AU740814B2 (ja) |
BR (1) | BR9805088A (ja) |
CA (1) | CA2252733A1 (ja) |
CZ (1) | CZ293913B6 (ja) |
DE (2) | DE19748469A1 (ja) |
DK (1) | DK0913396T3 (ja) |
ES (1) | ES2203867T3 (ja) |
HR (1) | HRP980576B1 (ja) |
HU (1) | HUP9802518A3 (ja) |
ID (1) | ID21209A (ja) |
IL (1) | IL126855A (ja) |
MY (1) | MY118262A (ja) |
NO (1) | NO985023L (ja) |
NZ (1) | NZ332575A (ja) |
PL (1) | PL329437A1 (ja) |
PT (1) | PT913396E (ja) |
RU (1) | RU2225403C2 (ja) |
SI (1) | SI0913396T1 (ja) |
SK (1) | SK284859B6 (ja) |
TR (1) | TR199802200A3 (ja) |
TW (1) | TW593307B (ja) |
ZA (1) | ZA989982B (ja) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5408940A (en) * | 1992-06-25 | 1995-04-25 | Winchell; Paul W. | Adjustable height work surface wtih rack and pinion arrangements |
DE19858253A1 (de) | 1998-12-17 | 2000-06-21 | Aventis Pharma Gmbh | Verwendung von Inhibitoren des KQt1-Kanals zur Herstellung eines Medikaments zur Behandlung von Krankheiten, die durch Helminthen und Ektoparasiten hervorgerufen werden |
KR100545780B1 (ko) * | 2003-05-28 | 2006-01-24 | 동부한농화학 주식회사 | 벤즈이미다졸 유도체로 치환된 벤조피란 유도체 또는약학적으로 허용되는 그의 염, 이의 제조 방법 및 이를포함하는 약학적 조성물 |
KR100512486B1 (ko) * | 2003-05-28 | 2005-09-06 | 동부한농화학 주식회사 | 싸이옥소벤즈옥사졸 유도체로 치환된 벤조피란 유도체또는 약학적으로 허용되는 염, 이의 제조방법 및 이를포함하는 약학적 조성물 |
DE602006016420D1 (de) * | 2005-04-12 | 2010-10-07 | Abbott Products Gmbh | Aminoalkylamidomethylsubstituierte 2-(4-sulfonylamino)-3-hydroxy-3,4-dihydro-2h-cromen-6-yl derivate und ihre verwendung als kaliumkanalblocker |
EP2595623B1 (en) | 2010-07-19 | 2018-02-28 | The U.S.A. as represented by the Secretary, Department of Health and Human Services | Use of delta tocopherol for the treatment of lysosomal storage disorders |
AU2013344651A1 (en) | 2012-11-16 | 2015-05-28 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Tocopherol and tocopheryl quinone derivatives as correctors of Lysosomal Storage Disorders |
WO2015047113A1 (en) * | 2013-09-30 | 2015-04-02 | Polfarmex S.A. | Novel substituted n, n-dimethylaminoalkyl ethers of isoflavanone oximes as η1-receptor antagonists |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3737195A1 (de) * | 1987-11-03 | 1989-05-18 | Bayer Ag | Chromanderivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln |
GB8808069D0 (en) * | 1988-04-07 | 1988-05-11 | Fujisawa Pharmaceutical Co | Benzopyran derivatives & processes for preparation thereof |
US5104890A (en) * | 1989-03-28 | 1992-04-14 | Fujisawa Pharmaceutical Company, Ltd. | Benzopyran derivatives and processes for preparation thereof |
PT807629E (pt) * | 1996-05-15 | 2004-07-30 | Aventis Pharma Gmbh | Cromanos substituidos por sulfonamidas processo para a sua preparacao a sua utilizacao como medicamentos ou agentes de diagnostico bem como medicamentos que os contem |
DE19706675A1 (de) * | 1997-02-20 | 1998-08-27 | Hoechst Ag | Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
DE19742508A1 (de) * | 1997-09-26 | 1999-04-01 | Hoechst Marion Roussel De Gmbh | Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen |
DE19742509A1 (de) * | 1997-09-26 | 1999-04-01 | Hoechst Marion Roussel De Gmbh | Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen |
-
1997
- 1997-11-03 DE DE19748469A patent/DE19748469A1/de not_active Withdrawn
-
1998
- 1998-10-28 NO NO985023A patent/NO985023L/no not_active Application Discontinuation
- 1998-10-28 PT PT98120379T patent/PT913396E/pt unknown
- 1998-10-28 ES ES98120379T patent/ES2203867T3/es not_active Expired - Lifetime
- 1998-10-28 DE DE59809628T patent/DE59809628D1/de not_active Expired - Lifetime
- 1998-10-28 SI SI9830559T patent/SI0913396T1/xx unknown
- 1998-10-28 AT AT98120379T patent/ATE250051T1/de not_active IP Right Cessation
- 1998-10-28 DK DK98120379T patent/DK0913396T3/da active
- 1998-10-28 EP EP98120379A patent/EP0913396B1/de not_active Expired - Lifetime
- 1998-10-30 AU AU90437/98A patent/AU740814B2/en not_active Ceased
- 1998-10-30 ID IDP981433A patent/ID21209A/id unknown
- 1998-10-30 PL PL98329437A patent/PL329437A1/xx not_active Application Discontinuation
- 1998-10-30 SK SK1494-98A patent/SK284859B6/sk unknown
- 1998-10-30 TR TR1998/02200A patent/TR199802200A3/tr unknown
- 1998-10-30 AR ARP980105473A patent/AR015997A1/es unknown
- 1998-10-30 NZ NZ332575A patent/NZ332575A/xx unknown
- 1998-10-30 TW TW087118010A patent/TW593307B/zh not_active IP Right Cessation
- 1998-11-02 HU HU9802518A patent/HUP9802518A3/hu unknown
- 1998-11-02 MY MYPI98004981A patent/MY118262A/en unknown
- 1998-11-02 IL IL12685598A patent/IL126855A/xx not_active IP Right Cessation
- 1998-11-02 CZ CZ19983508A patent/CZ293913B6/cs not_active IP Right Cessation
- 1998-11-02 RU RU98119955/04A patent/RU2225403C2/ru not_active IP Right Cessation
- 1998-11-02 US US09/184,110 patent/US6008245A/en not_active Expired - Lifetime
- 1998-11-02 HR HR980576A patent/HRP980576B1/xx not_active IP Right Cessation
- 1998-11-02 ZA ZA989982A patent/ZA989982B/xx unknown
- 1998-11-02 JP JP31194798A patent/JP4430749B2/ja not_active Expired - Fee Related
- 1998-11-03 CN CN98123865A patent/CN1218050A/zh active Pending
- 1998-11-03 CA CA002252733A patent/CA2252733A1/en not_active Abandoned
- 1998-11-03 BR BR9805088A patent/BR9805088A/pt not_active Application Discontinuation
- 1998-11-03 KR KR1019980046904A patent/KR19990044961A/ko not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1194403T3 (da) | Indanylsubstituerede benzencarboxamider, fremgangsmåde til deres fremstilling, deres anvendelse som lægemiddel samt farmaceutiske tilberedninger med indhold deraf | |
NO20032735L (no) | Difenylazetidinonderivater, fremgangsmåte for deres fremstilling, legemidler som inneholder disse forbindelsene samt deres anvendelse | |
NO973923L (no) | Nye taxoider, deres fremstilling samt farmasöytiske preparater inneholdende forbindelsene | |
NO20032187L (no) | Heterocyklylalkylpiperidinderivater, deres fremstilling samt preparater inneholdende forbindelsene | |
NO972211D0 (no) | Sulfonamid-substituerte kromaner, deres fremstilling, deres anvendelse som medikament eller diagnostikum samt medikamenter inneholdende kromanene | |
NO20021398D0 (no) | 2'-substituerte 1,1'-bifenyl-2-karbonamider, fremgangsmåte for fremstilling, deres anvendelse som medikament såvel somfarmasöytiske preparater inneholdende disse | |
NO980273L (no) | Femleddede heterocykluser med bifenylsulfonylsubstitusjon fremgangsmÕte for deres fremstilling, deres anvendelse som medikament eller diagnostikum samt medikament inneholdende forbindelsen | |
NO951283D0 (no) | Nye taxanderivater, deres fremstilling samt farmasöytiske preparater inneholdende derivatene | |
NO984476L (no) | Sulfonamidsubstituerte kromaner, fremgangsmÕte for fremstilling derav, deres anvendelse som medikament samt farmas°ytiske preparater inneholdende forbindelsene | |
NO20022801D0 (no) | Substituerte norbornylaminoderivater, fremgangsmåte for deres fremstilling, deres anvendelse som medikament eller diagnostikumsåvel som medikamenter inneholdende disse | |
NO972433L (no) | Substituerte 2-naftoylguanidiner, fremgangsmåter for deres fremstilling, deres anvendelse som medikament eller diagnostikum samt medikamenter inneholdende forbindelsene | |
NO985023D0 (no) | Sulfonamidsubstituerte benzopyranderivater, fremgangsmÕter for deres fremstilling, deres anvendelse som medikament samt farmas°ytiske preparater inneholdende forbindelsene | |
DK1118610T3 (da) | Benzensulfonamid-derivater, fremgangsmåde til fremstilling heraf samt farmaceutiske sammensætninger indeholdende derivaterne | |
DK303688D0 (da) | Polyoxygenerede labdanderivater, fremgangsmaade til deres fremstilling samt deres anvendelse som laegemidler | |
NO974563D0 (no) | Nye taxoider, deres fremstilling samt farmasöytiske preparater inneholdende forbindelsene | |
NO984475D0 (no) | Sulfonamidsubstituerte kromaner, fremgangsmÕte for fremstilling derav, deres anvendelse som medikament samt farmas°ytiske preparater inneholdende forbindelsene | |
NO985171D0 (no) | Sulfonamidsubstituerte kondenserte 5-ringforbindelser, deres anvendelse som medikament samt farmas°ytiske preparater inneholdende forbindelsene | |
DK393788D0 (da) | Substituerede thienoimidazolderivater, fremgangsmaader til deres fremstilling samt deres anvendelse som laegemidler | |
NO980785D0 (no) | Sulfonamidsubstituerte kondenserte 7-ringforbindelser, deres anvendelse som medikament samt farmasöytiske preparater inneholdende forbindelsene | |
BR0009281B1 (pt) | derivados de morfolina, processo de preparação dos mesmos, composições farmacêuticas que os contêm, uso dos referidos derivados e medicamento. | |
NO983577D0 (no) | Sulfonamidsubstituerte forbindelser, fremgangsmåter for deres fremstilling, deres anvendelse som medikament eller diagnostikum, samt medikament inneholdende forbindelsen | |
NO972434D0 (no) | Substituerte 1-naftoylguanidiner, fremgangsmåte for fremstilling derav, deres anvendelse som medikament eller diagnostikum samt medikamenter inneholdende forbindelsene | |
NO990675L (no) | 11-acetyl-12,13-dioksabisyklo[8.2.1.]-tridekenonderivater, fremgangsmåter for deres fremstilling, samt legemidler inneholdende slike forbindelser | |
NO980564D0 (no) | Sulfonamid-substituerte forbindelser, fremgangsmåte for fremstilling, anvendelse som medikament eller diagnostikum samt oppnådd medikament er beskrevet | |
DK225189A (da) | Hydrazinocarbonyloxylabdaner, fremgangsmaade til deres fremstilling samt deres anvendelse som laegemidler |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |